Albumin is an appealing carrier in nanomedicine because of its unique features. First, it is
the most abundant protein in plasma, endowing high biocompatibility, biodegradability …

Biosafety is the primary concern in clinical translation of nanomedicine. As an intrinsic
ingredient of human blood without immunogenicity and encouraged by its successful clinical …

Paclitaxel (PTX) is among the most commonly used first-line drugs for cancer chemotherapy.
However, its poor water solubility and indiscriminate distribution in normal tissues remain …

Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

To achieve superior therapeutic efficacy, the combination chemotherapy using two or more
anticancer drugs in clinical practice has been generally accepted as a feasible strategy. On …

Mesangial cells-mediated glomerulonephritis is a frequent cause of end-stage renal
disease. Here, we show that celastrol is effective in treating both reversible and irreversible …

Nanocarriers can deliver drugs to specific organs or cells, potentially bridging the gap
between a drug's function and its interaction with biological systems such as human …

Human serum albumin nanoparticles (HSA-NPs) are widely-used drug delivery systems with
applications in various diseases, like cancer. For intravenous administration of HSA-NPs …

Abstracts A major challenge in the field of nanomedicine is to transform laboratory
innovations into commercially successful clinical products. In this campaign, a variety of …

Simple Summary Bone represents a common metastatic site for patients with advanced
cancers while also being associated with rare but challenging primary tumors. As the …